botox pd.inj.sol 50u/vial
abbvie ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. abbvie a.e. Μαρίνου Αντύπα 41-45,, 141 21 141 21, Νέο Ηράκλειο 214 4165 555 - botulinum toxin type a - pd.inj.sol (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 50u/vial - botulinum toxin type a 50u - botulinum toxin
botox pd.inj.sol 200u/vial
abbvie ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. abbvie a.e. Μαρίνου Αντύπα 41-45,, 141 21 141 21, Νέο Ηράκλειο 214 4165 555 - botulinum toxin type a - pd.inj.sol (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 200u/vial - botulinum toxin type a 200u - botulinum toxin
vistabel pd.inj.sol 50 units/vial
abbvie ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. abbvie a.e. Μαρίνου Αντύπα 41-45,, 141 21 141 21, Νέο Ηράκλειο 214 4165 555 - botulinum toxin type a - pd.inj.sol (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 50 units/vial - botulinum toxin type a 50u - botulinum toxin
vistabel 4 allergan units/0.1ml powder for solution for injection
abbvie pharmaceuticals s.a. (0000010106) 41-45 marinou antipa str., athens, 14121 - botulinum toxin type a - powder for solution for injection - 4 allergan units/0.1ml - botulinum toxin type a (8000002098) 4au - botulinum toxin
bocouture 50u powder for solution for injection
merz pharmaceuticals gmbh (0000001432) eckenheimer landstrasse 100, frankfurt, 60318 - clostridium botulinum neurotoxin type a - powder for solution for injection - 50u - clostridium botulinum neurotoxin type a (8000004336) 0,4mg
bocouture 100u powder for solution for injection
merz pharmaceuticals gmbh (0000001432) eckenheimer landstrasse 100, frankfurt, 60318 - clostridium botulinum neurotoxin type a - powder for solution for injection - 100u - clostridium botulinum neurotoxin type a (8000004336) 0,8mg
suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - Χοίροι - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.
botox 200 units powder for solution for injection
abbvie pharmaceuticals s.a. (0000010106) 41-45 marinou antipa str., athens, 14121 - botulinum toxin type a - powder for solution for injection - 200 units - botulinum toxin type a (8000002098) 200u - botulinum toxin
botox 100 units powder for solution for injection
abbvie pharmaceuticals s.a. (0000010106) 41-45 marinou antipa str., athens, 14121 - botulinum toxin type a - powder for solution for injection - 100 units - botulinum toxin type a (8000002098) 100u - botulinum toxin
botox 50 units powder for solution for injection
abbvie pharmaceuticals s.a. (0000010106) 41-45 marinou antipa str., athens, 14121 - botulinum toxin type a - powder for solution for injection - 50 units - botulinum toxin type a (8000002098) 50u - botulinum toxin